Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

60.0%

3 terminated/withdrawn out of 5 trials

Success Rate

25.0%

-61.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2
3(60.0%)
N/A
2(40.0%)
5Total
Phase 2(3)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03746132Not ApplicableUnknown

Oxygen for Vascular Incisional Healing

Role: lead

NCT02617706Phase 2Withdrawn

Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Colon Surgery

Role: lead

NCT02615379Not ApplicableWithdrawn

Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Instrumented Fusion

Role: lead

NCT02374294Phase 2Withdrawn

TCOT Effectiveness in Preventing Wound Infections in Perineal Resections

Role: lead

NCT01291160Phase 2Completed

Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers

Role: lead

All 5 trials loaded